Stock MBOT MICROBOT MEDICAL INC.
Add to a list
To use this feature you must be a member
Log inSign up

Microbot Medical Inc. Stock

Equities

MBOT

US59503A2042

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-04-26 EDT 		5-day change 1st Jan Change
0.88 USD +1.95% Intraday chart for Microbot Medical Inc. +1.73% -46.34%
04-16 HC Wainwright Adjusts Microbot Medical's Price Target to $7 From $8, Keeps Buy Rating MT
03-27 Microbot Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Financials

Sales 2024 * - Sales 2025 * - Capitalization 12.67M 17.32M
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * -
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * -
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees 22
Yield 2024 *
-
Yield 2025 *
-
Free-Float 98.32%
More Fundamentals * Assessed data

Chart Microbot Medical Inc.

Dynamic Chart

Latest news about Microbot Medical Inc.

HC Wainwright Adjusts Microbot Medical's Price Target to $7 From $8, Keeps Buy Rating MT
Microbot Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Microbot Medical Submits US FDA Application to Start Human Clinical Trial for Robotic Surgical System MT
Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US CI
Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study CI
Sector Update: Health Care Stocks Ease Friday Afternoon MT
Microbot Medical to Exercise Outstanding Preferred Investment Options for $2.7 Million MT
Sector Update: Health Care Stocks Rise in Late Afternoon MT
Microbot Medical Says GLP Preclinical Study of Liberty Endovascular Robotic Surgical System Met Objectives; Shares Rise MT
Sector Update: Health Care Stocks Advance Thursday Afternoon MT
Microbot Medical Announces Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Met CI
Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY Endovascular Robotic Surgical System for Telerobotic CI
Microbot Medical Announces the Successful Completion of its GLP Pivotal Pre-Clinical Study CI
Microbot Medical Inc. Announces Executive Changes CI
Microbot Medical Files $75 Million Shelf MT
More news

Analyst Recommendations on Microbot Medical Inc.

HC Wainwright Adjusts Microbot Medical's Price Target to $7 From $8, Keeps Buy Rating MT
HC Wainwright Adjusts Price Target on Microbot Medical to $8 From $20, Keeps Buy Rating MT
More recommendations

Press releases Microbot Medical Inc.

Microbot Medical Shares Status Following Recent Geopolitical Events GL
Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US GL
Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters GL
Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study GL
Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study AQ
More press releases

Quotes and Performance

1 day+1.95%
1 week+1.73%
Current month-28.46%
1 month-23.48%
3 months-30.71%
6 months-24.14%
Current year-46.34%
More quotes

Highs and lows

1 week
0.86
Extreme 0.861
0.91
1 month
0.86
Extreme 0.8601
1.35
Current year
0.86
Extreme 0.8601
1.63
1 year
0.86
Extreme 0.8601
4.37
3 years
0.86
Extreme 0.8601
9.60
5 years
0.86
Extreme 0.8601
20.15
10 years
0.86
Extreme 0.8601
192.03
More quotes

Managers and Directors - Microbot Medical Inc.

Managers TitleAgeSince
Harel Gadot CEO
 Chief Executive Officer 52 88-08-01
Rachel Vaknin DFI
 Director of Finance/CFO 45 21-12-31
Juan Diaz-Cartelle CTO
 Chief Tech/Sci/R&D Officer - 11-30
Members of the board TitleAgeSince
Scott Burell BRD
 Director/Board Member 59 16-11-27
Laxmin Laxminarain BRD
 Director/Board Member 66 17-12-11
Tal Wenderow BRD
 Director/Board Member 50 20-07-31
More insiders

Quotes

Date Price Change Volume
24-04-26 0.88 +1.95% 31,899
24-04-25 0.8632 -3.12% 74,549
24-04-24 0.891 +1.26% 82,757
24-04-23 0.8799 -0.86% 88,648
24-04-22 0.8875 +2.60% 125,298

Delayed Quote Nasdaq, April 26, 2024 at 04:30 pm

More quotes

Company Profile

Microbot Medical Inc. is a pre-clinical medical device company. The Company is specializing in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is primarily focused on leveraging its robotic technologies with surgical robotics to improve surgical outcomes for patients. Its technological platforms include LIBERTY and NovaCross. Using its LIBERTY Endovascular Robotic Surgical System, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. LIBERTY Endovascular Robotic Surgical System addresses the needs of interventional cardiology, interventional radiology and interventional neuroradiology markets.
Sector
Biotechnology & Medical Research
More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.88 USD
Average target price
7 USD
Spread / Average Target
+695.45%
Consensus

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
MICROBOT MEDICAL INC. Stock Microbot Medical Inc.
-46.34% 12.67M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. MBOT Stock